MSMathieu Scalabrini

Mathieu Scalabrini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mathieu Scalabrini has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hydrophilic Cyclic Poly(oxa)Norbornene Platforms via Ring‐Expansion Metathesis Polymerization (REMP) for Lectin Binding Inhibition

    by Clément Gonnot, Mathieu Scalabrini, Benoit Roubinet, Fabien Boeda, David Deniaud, Ludovic Landemarre, Sébastien G. Gouin, Laurent Fontaine, Véronique Montembault

    This study presents the synthesis of cyclic poly(oxanorbornenyl azlactone) ( c‐PONBSAzl ) and poly(norbornenyl azlactone) ( c‐PNBSAzl ) via ring‐expansion metathesis polymerization (REMP). These polymers differ by a single oxygen‐for‐carbon substitution in the backbone, offering a unique platform to investigate how this structural variation influences REMP kinetics, solubility, and lectin‐binding properties. Reactivity studies revealed distinct polymerization behaviors, underscoring the significant impact of the oxanorbornene backbone on REMP efficiency. Subsequent post‐polymerization modification (PPM) by aminolysis with heptyl mannose yielded cyclic glycopolymers with a number‐average degree of polymerization ( DP n ) ≈ 140. In aqueous solution, both cyclic architectures showed excellent solubility, with the oxanorbornene backbones demonstrating higher local mobility and reduced intermolecular association. Binding assays were performed against five therapeutically relevant mannose‐binding lectins (FimH, Bc2L‐A, ConA, DC‐SIGN, and Langerin). Notably, the increased local mobility imparted by the oxanorbornene backbone did not translate into a measurable enhancement in lectin inhibition relative to the norbornene analogue. Instead, both cyclic architectures exhibited strong multivalent interactions and achieved nanomolar‐range inhibition against both lectins. These results reinforce cyclic glycopolymers as potent multivalent lectin binders and broaden their structural and functional scope, establishing them as promising platforms for hydrophilic glycomaterial design.

  • Étude de l'activité anti-bioadhésion de surfaces de verres greffées par des sucres furanosidiques rares

    by Mathieu Scalabrini

    La biocontamination de surface par des microorganismes provoque d’importantes conséquences économiques et sanitaires. Les différents moyens de prévention mis en place de nos jours utilisent des composés biocides nocifs pour l’environnement et participent à la recrudescence de l’antibiorésistance des organismes pathogènes. Ces travaux de recherche étudient une approche alternative non-biocide et non-toxique. Elle consiste à inhiber l’adhésion microbienne en appliquant une couche de monofuranosides sur une surface. La conception des surfaces a débuté par les synthèses glycosidiques des furanosides cibles à partir du D-Glucose, D-Galactose et D- Mannose. Des homologues pyranosidiques, connus pour leur activité antiadhésive, ont été réalisés afin de comparer l’intérêt de la forme cyclique. Ces sucres ont ensuite été greffés par chimie click sur une surface de verre préfonctionnalisée et au travers d’un lien O-glycosidique ou S- glycosidique via un groupe triazole. Les surfaces résultantes ont été caractérisées à l’aide de la goniométrie et de la spectroscopie photoélectron par rayons X. Les études d’adhésion avec Pseudomonas aeruginosa ont révélé une activité anti-biodhésion des surfaces furanosidiques et pyranosidiques. Les interactions spécifiques et non-spécifiques ont été explorées gràce à l’adhésion de mutants déficiants en lectine et d’un modèle thermodynamique. Les résultats ont conclu que l’activité antiadhésive des monosaccharides était davantage liée aux propriétés physicochimiques des sucres plutôt qu’à des interactions biologiques.

  • Open Access

    Ultrafast tyrosine-based cell membrane modification via diazonium salts: A new frontier for biomedical applications

    by Mohammed Bouzelha, Karine Pavageau, Sarah Renault, Enora Ferron, Nicolas Jaulin, Maia Marchand, Dimitri Alvarez-Dorta, Roxanne Peumery, Mathieu Scalabrini, Héloïse Delépée, et al.

  • Open Access

    Targeting Sialic Acid Catabolism with Polyvalent Sialidase Inhibitors to Mitigate Bacterial Inflammation in the gut

    by Mélyne Baudin Marie, Zoé Oblette, Mathieu Scalabrini, Denis Loquet, Devon Kavanaugh, David Deniaud, Thomas Bessonnet, Nizar Amzil, Aziz Elgarrab, Cyrille Grandjean, et al.

    Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic inflammatory disorders strongly associated with intestinal dysbiosis and the overgrowth of pro-inflammatory Enterobacteriaceae. A key driver of this imbalance is microbial mucin degradation, which liberates sialic acids that in turn fuel the expansion of pathogenic bacteria. Inhibiting sialic acid catabolism therefore represents a promising anti-virulence strategy to restore intestinal homeostasis. In this study, we designed and synthesized (neo)glycopolymers bearing sialic acid analogues as polyvalent inhibitors of bacterial sialidases (SA) and sialate O-acetylesterases (SIAE), the enzymes responsible for cleaving sialic acids and removing O-acetyl groups from acetylated sialic acids coating protective mucins. Three glycopolymers were developed, incorporating either a non-hydrolyzable free thiosialoside motif, a C-9 acetylated thiosialoside motif, or a transition-state analogue (poly-S-Neu5Ac2en100). These polymeric inhibitors exhibited strong multivalent effects, with poly-S-Neu5Ac2en100 achieving subnanomolar potency against the Bacteroides sialidases BtSA and BvSA, far exceeding the efficacy of their monovalent counterparts. Functional assays revealed that poly-S-Neu5Ac2en100 effectively blocked mucin desialylation and strongly suppressed the growth of adherent-invasive Escherichia coli (AIEC), a pathobiont frequently linked to Crohn’s disease. However, preliminary in vivo experiments in a murine colitis model did not yield robust improvements in disease activity, likely reflecting the limitations of adequately reproducing chronic disease in this model. Overall, our findings establish polyvalent sialidase inhibitors as exceptionally potent blockers of bacterial SA and valuable chemical tools to probe the role of sialic acid metabolism in dysbiosis.

  • Open Access

    Ultrafast tyrosine-based cell membrane modification via diazonium salts: a new frontier for biomedical applications

    by Mohammed Bouzelha, Karine Pavageau, Sarah Renault, Enora Ferron, Nicolas Jaulin, Maia Marchand, Dimitri Alvarez-Dorta, Roxanne Peumery, Mathieu Scalabrini, Héloïse Delépée, et al.

    In this study, we present an ultrafast, efficient, and broadly applicable strategy for cell membrane modification via tyrosine bioconjugation using diazonium salt derivatives. This chemical approach enables both one-step and two-step functionalization of adherent, suspension, and primary cells with diverse ligands, including imaging probes, carbohydrates, biotin, and proteins, without inducing cytotoxicity or immune activation. Membrane engineering through bioconjugation is emerging as a valuable tool in biomedical research, given the cell membrane’s central role in signaling, transport, and cell-cell interactions. Compared to traditional glyco-engineering methods that often require multiday incubations and can cause cellular stress, our approach achieves precise and high-density grafting in less than one hour, with improved reproducibility and biological compatibility. Importantly, we demonstrate that this strategy can be applied to a variety of cell types, encompassing both immortalized cell lines and primary cells, notably Peripheral Blood Mononuclear Cells (PBMCs) and human effector cells such as natural killer (NK) cells, to enhance their cytotoxic function against EGFR-positive cancer cells via surface-conjugated Nanofitin. Moreover, we show that the bioconjugated signal diminishes over time due to cell division, offering a self-limiting alternative to permanent genetic modifications such as CAR-T, thereby mitigating risks associated with overly prolonged immune activation. Finally, the feasibility of storing pre-functionalized cells at -80 °C expands the practicality of this platform for future ready-to-use applications. Together, these features make our method a compelling alternative to current technologies for applications in targeted therapy, diagnostics, and cell-based immunotherapy.

  • Open Access

    Multivalent Inhibition of the Aspergillus fumigatus KDNase

    by Mathieu Scalabrini, Denis Loquet, Camille Rochard, Mélyne Baudin-Marie, Coralie Assailly, Yoan Brissonnet, Franck Daligault, Amélie Saumonneau, Annie Lambert, Cyrille Grandjean, et al.

    Aspergillus fumigatus is a saprophytic fungus and opportunistic pathogen often causing fatal infections in immunocompromised patients. Recently AfKDNAse, an exoglycosidase hydrolyzing 2-keto-3-deoxynononic acid (KDN), a rare sugar from the sialic acid familly, was identified and characterized. The principal function of AfKDNAse is still unclear, but a study suggest a critical role in fungal cell wall morphology and virulence. Potent AfKDNAse inhibitors are required to better probe the enzyme’s biological role and as potential antivirulence factors. In this work, we developed a set of AfKDNAse inhibitors based on enzymatically stable thio-KDN motifs. C2, C9-linked heterodi-KDN were designed to fit into unusually close KDN sugar binding pockets in the protein. A polymeric compound with an average of 54 KDN motifs was also designed by click chemistry. Inhibitory assays performed on recombinant AfKDNAse showed a moderate and strong enzymatic inhibition for the two classes of compounds, respectively. The Poly-KDN showed more than a nine hundred fold improved inhibitory activity (IC50 = 1.52 ± 0.37µM, 17-fold in a KDN molar basis) compared to a monovalent KDN reference, and is to our knowledge, the best synthetic inhibitor described for a KDNase. Multivalency appears to be a relevant strategy for the design of potent KDNase inhibitors. Importantly, poly-KDN was shown to strongly decrease filamentation when co-cultured with A. fumigatus at micromolar concentrations, opening interesting perspectives in the development of antivirulence factors.

  • Pseudomonas aeruginosa resistance of monosaccharide-functionalized glass surfaces

    by Mathieu Scalabrini, Jonathan Hamon, Isabelle Linossier, Vincent Ferrières, Karine Réhel